Status:
COMPLETED
The Effect of OMM in the Treatment of Primary Dysmenorrhea Symptoms
Lead Sponsor:
New York Institute of Technology
Conditions:
Dysmenorrhea Primary
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Primary dysmenorrhea or simply painful menstruation is a disorder that 45-90% of women experience to varying degrees. The most prominent symptom of dysmenorrhea is crampy suprapubic pain occurring pri...
Detailed Description
Subjects will participate in an initial zoom session for a detailed gynecological and medical history. A thorough social history including diet description and exercise routine will also be obtained. ...
Eligibility Criteria
Inclusion
- Complaints of menstrual-related pain over past 2 years
- Regular menstrual cycles, with menstruation lasting at least 2-5 days for past 2 years
- Occurrence of a regular menstrual cycle within past 40 days
- Complaint of dysmenorrhea symptoms with a severity of at least 5/10 on the Visual Analog Scale
Exclusion
- Presence of Pelvic Pathology (endometriosis, leiomyomata, adenomyosis, pelvic inflammatory disease, etc)
- Known Hormonal Imbalance (PCOS, Ovarian Disorder, etc)
- Oral Contraceptive Use
- Presence of IUD (Copper or Hormone Eluting)
- Oligomenorrhea/Amenorrhea
- Pregnancy
- Under age 18 yo
- Positive COVID-19 serological testing
Key Trial Info
Start Date :
February 16 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 16 2024
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT05208476
Start Date
February 16 2022
End Date
April 16 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Riland Academic Health Care Center
Old Westbury, New York, United States, 11545